Invention Grant
- Patent Title: Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
- Patent Title (中): 使用清道夫受体类蛋白抑制剂治疗传染病
-
Application No.: US13548777Application Date: 2012-07-13
-
Publication No.: US08507546B2Publication Date: 2013-08-13
- Inventor: Michael Hannus , Cecilie Martin , Maria M. Mota , Miguel Prudencio , Christina Dias Rodrigues
- Applicant: Michael Hannus , Cecilie Martin , Maria M. Mota , Miguel Prudencio , Christina Dias Rodrigues
- Applicant Address: PT Lisboa DE Dresden
- Assignee: Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa,Cenix Bioscience GmbH
- Current Assignee: Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa,Cenix Bioscience GmbH
- Current Assignee Address: PT Lisboa DE Dresden
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP06004854 20060309
- Main IPC: A01N43/02
- IPC: A01N43/02 ; A01N43/18 ; A61K31/38
Abstract:
The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.
Public/Granted literature
- US20120276121A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES Public/Granted day:2012-11-01
Information query
IPC分类:
